(Press-News.org) The last two decades have seen tremendous progress in understanding the genetic basis of human brain disorders. Research developments in this area have revealed fundamental insights into the genes and molecular pathways that underlie neurological and psychiatric diseases. In a new series of review articles published by Cell Press in the October 21 issue of the journal Neuron, experts in the field discuss exciting recent advances in neurogenetics research and the potential implications for the treatment of these devastating disorders.
Genetic discoveries have transformed clinical practice in neurology and psychiatry and provided new hope for many patients and their families. Recent advances in sequencing technologies coupled with improved analytical and computational approaches have led an amazing pace of discovery of genes linked to human disease. The complexity of neuropsychiatric and neurological disorders is apparent in the fast-growing list of genetic defects linked to these diseases. These genetic findings have provided key insight into underlying causes of these disorders and inspired further research aimed at prevention and therapy.
Genetic research has great potential for revolutionizing the treatment of human disease. However, the translation of genetic findings into the development of new disease therapies can take time. In an overview of the series, researchers Huda Zoghbi from Baylor College of Medicine and Stephen Warren from Emory University School of Medicine discuss recent achievements in neurogenetics research and the promise that it holds for disease treatment. They point out that gene discovery is a critical first step in the path to development of new therapies and that follow up investigations are needed to reveal disease pathways that lend themselves to therapeutic intervention. These preclinical investigations are a key step in the translation of genetic discoveries to clinical applications. Recent data from mouse disease models indicate that some developmental and degenerative diseases are reversible. These findings provide hope that genetic discoveries could potentially lead to the reversal of serious neurological and psychiatric disorders through the development of therapeutics that suppress the pathways contributing to disease.
Zoghbi and Warren make a strong case for the need for scientific collaboration and the appropriate infrastructure to support partnerships among academic research, governments, private institutions and foundations, and pharmaceutical industries. The authors argue that combining resources and expertise will help accelerate the development of therapies based on genetic discoveries.
INFORMATION:
This series of review articles covers a wide spectrum of recent research in neurogenetics, including the genetics of Parkinson and Alzheimer disease, human developmental and neurogenetics, and the genetics of child psychiatric disorders. All articles are freely available on the Neuron website (www.neuron.org) for a limited time.
Reviews:
Neurogenetics: Advancing the ''Next-Generation'' of Brain Research H.Y. Zoghbi and S.T. Warren
Tangles of Neurogenetics, Neuroethics, and Culture E. Brief and J. Illes
Healing Genes in the Nervous System X.O. Breakefield and M. Sena-Esteves
The Psychiatric GWAS Consortium: Big Science Comes to Psychiatry P.F. Sullivan
Changing the Landscape of Autism Research: The Autism Genetic Resource Exchange C.M. Lajonchere and the AGRE Consortium
The Simons Simplex Collection: A Resource for Identification of Autism Genetic Risk Factors G.D. Fischbach and C. Lord
Nature versus Nurture: Death of a Dogma, and the Road Ahead B.J. Traynor and A.B. Singleton
Genetic Analysis of Pathways to Parkinson Disease J. Hardy
From Single Genes to Gene Networks: High-Throughput-High-Content Screening for Neurological Disease S. Jain and P. Heutink
Neurocognitive Phenotypes and Genetic Dissection of Disorders of Brain and Behavior E. Congdon, R.A. Poldrack, and N.B. Freimer
Human Brain Evolution: Harnessing the Genomics (R)evolution to Link Genes, Cognition, and Behavior G. Konopka and D.H. Geschwind
Allelic Diversity in Human Developmental Neurogenetics: Insights into Biology and Disease C.A. Walsh and E.C. Engle
The Genetics of Child Psychiatric Disorders: Focus on Autism and Tourette Syndrome M.W. State
The Genetics of Alzheimer Disease: Back to the Future L. Bertram, C.M. Lill, and R.E. Tanzi
Episodic Neurological Channelopathies D.P. Ryan and L.J. Ptácek
Hearing Impairment: A Panoply of Genes and Functions A.A. Dror and K.B. Avraham
Genetic Advances in the Study of Speech and Language Disorders D.F. Newbury and A.P. Monaco
Neurogenetics research sheds light on the causes of neurological disease
2010-10-21
ELSE PRESS RELEASES FROM THIS DATE:
Gene therapy may be powerful new treatment for major depression
2010-10-21
NEW YORK (Oct. 20, 2010) -- In a report published in the Oct. 20 issue of Science Translational Medicine, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say animal and human data suggest gene therapy to the brain may be able to treat patients with major depression who do not respond to traditional drug treatment.
The researchers hope to rapidly translate their findings into a human clinical trial using the same kind of gene therapy modality the investigators have pioneered to treat Parkinson's disease. A 45-patient randomized blinded phase II ...
Surgical aortic valve replacement should remain the standard treatment for aortic stenosis
2010-10-21
(Boston) - Despite the promising results of the "Placement of Aortic Transcatheter Valves (PARTNER) trial," featured in the Oct. 21 issue of the New England Journal of Medicine, a cardiothoracic surgeon from Boston Medical Center (BMC) believes that surgical aortic-valve replacement should remain the standard treatment of aortic stenosis. In the accompanying editorial, the author argues that Transcatheter aortic-valve implantation (TAVI) should be reserved for patients at inordinately high risk who are not suitable candidates for surgery and who have decreased life expectancy. ...
Energy revolution key to complex life
2010-10-21
The evolution of complex life is strictly dependent on mitochondria, the tiny power stations found in all complex cells, according to a new study by Dr Nick Lane, from UCL (University College London), and Dr William Martin, from the University of Dusseldorf.
"The underlying principles are universal. Energy is vital, even in the realm of evolutionary inventions," said Dr Lane, UCL Department of Genetics, Evolution and Environment. "Even aliens will need mitochondria."
For 70 years scientists have reasoned that evolution of nucleus was the key to complex life. Now, in ...
Star, not so bright
2010-10-21
In a galaxy far away, an exceptionally massive black hole is traveling around a massive star in an unusually tight orbit. Also odd, the star is not as bright as it should be.
Astronomers have puzzled over this X-ray binary system, named M33 X-7, but no one could explain all of its features. Now a Northwestern University research team has.
The researchers have produced a model of the system's evolutionary history and formation that explains all of the system's observational characteristics: the tight orbit, the large masses of the star and black hole, the X-ray luminosity ...
New space research settles years of scientific debate
2010-10-21
New space research published this week (Thursday 21 October) in the journal Nature, has settled decades of scientific debate. Researchers from the University of California (UCLA) and British Antarctic Survey (BAS) have found the final link between electrons trapped in space and the glow of light from the upper atmosphere known as the diffuse aurora. The research will help us understand 'space weather', with benefits for the satellite, power grid and aviation industries, and how space storms affect the Earth's atmosphere from the top down.
Scientists have long understood ...
Clearing the cosmic fog
2010-10-21
A European team of astronomers using ESO's Very Large Telescope (VLT) has measured the distance to the most remote galaxy so far. By carefully analysing the very faint glow of the galaxy they have found that they are seeing it when the Universe was only about 600 million years old (a redshift of 8.6). These are the first confirmed observations of a galaxy whose light is clearing the opaque hydrogen fog that filled the cosmos at this early time. The results will be presented at an online press conference with the scientists on 19 October 2010, and will appear in the 21 October ...
UT MD Anderson scientists show TAp63 suppresses cancer metastasis
2010-10-21
HOUSTON - Long overshadowed by p53, its famous tumor-suppressing sibling, the p63 gene does the tougher, important job of stifling the spread of cancer to other organs, researchers at The University of Texas MD Anderson Cancer Center report in the Oct. 21 issue of Nature.
Not only does a specific form of p63 protein block metastasis, but it does so by activating the enzyme Dicer, which plays a pivotal role in the creation of micro RNAs, tiny bits of RNA that regulate a host of cellular processes.
"p63 is a master regulator of metastasis, an important role in its own ...
Mount Sinai researchers find potential therapeutic target across a range of cancer types
2010-10-21
Researchers from Mount Sinai School of Medicine, in collaboration with investigators of the National Institute of Health and Medical Research (INSERM) of France led by Nicolae Ghinea, PhD, have found a common link among several malignant tumor types in all grades of cancer. This breakthrough may ultimately provide a new diagnostic or therapeutic target to detect cancer early or stop tumor growth. The study is published in the October 21 issue of The New England Journal of Medicine.
The team discovered that a hormone receptor typically found in human reproductive organs ...
New tumor proteins may identify a range of cancers early
2010-10-21
COLUMBUS, Ohio – A new study led by Ohio State University cancer researchers describes a novel cancer-specific protein that is present in a broad range of cancer types and at all stages of tumor development, from premalignant cells to metastatic tumor cells.
If verified, the antigen could serve as a marker for the early detection and treatment of primary and metastatic tumors, and provide a target for the development of anticancer therapies, the researchers say.
In addition, a vaccine designed to target these cancer-cell proteins, called Piwil2-like (PL2L) proteins, ...
New industrial application for revolutionary forensic metal fingerprinting technique
2010-10-21
Groundbreaking research into fingerprint detection developed at the University of Leicester now has an industrial application, thanks to a new invention by the scientist who developed the technique.
Dr John Bond's method of identifying fingerprints on brass bullet-casings, even after they have been wiped clean, was based on the minuscule amounts of corrosion which can be caused by sweat. First announced in 2008, this breakthrough was cited as one of the technologies 'most likely to change the world' by a panel of experts for BBC Focus magazine and was included in Time ...